Ting Ma

ORCID: 0000-0002-3033-0778 · 6 papers in corpus
observational 2025
Innovation in aging ·doi:10.1093/geroni/igaf090

BACKGROUND AND OBJECTIVES: Multimorbidity is increasingly prevalent among the middle-aged population, yet it is largely often overlooked. We aimed to explore and compare the differences in multimorbidity patterns by sex and age among middle…

observational 2025
BMC public health ·doi:10.1186/s12889-025-24201-1

BACKGROUND: Multimorbidity substantially increases health and economic burdens, and reduces productivity in working-age individuals. We conducted a study using data from 393,170 working-age inpatients (18-59 years) in Shaanxi, China, collec…

observational 2023
BMC medicine ·doi:10.1186/s12916-023-03204-y

BACKGROUND: Multimorbidity is better prevented in younger ages than in older ages. This study aims to identify the differences in comorbidity patterns in middle-aged inpatients from China and the United Kingdom (UK). METHODS: We utilized 1…

lab-animal 2021
Frontiers in pharmacology ·doi:10.3389/fphar.2020.588549

Guizhi Fuling prescription (GFP), a prestigious prescription of traditional Chinese medicine (TCM) recorded in "Jingui Yaolue," was composed of five Chinese medicines, including Moutan Cortex, Paeoniae Radix Alba, Persicae Semen, Poria Coco…

other 2021
Trials ·doi:10.1186/s13063-021-05614-w

BACKGROUND: Infertility is a widespread global challenge. Currently, the most effective treatment strategy for infertility is in vitro fertilization (IVF), which is an assisted reproductive technique (ART). The use of IVF for assisted pregn…

other 2020
Trials ·doi:10.1186/s13063-020-04502-z

BACKGROUND: Approximately 15% of couples in the reproductive age are affected by infertility. Women with diminished ovarian reserves (DOR) or with a poor ovarian response (POR) are required to undergo in vitro fertilization and embryo trans…